These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

407 related items for PubMed ID: 17467649

  • 1. Indocyanine green angiography: guided photodynamic therapy for polypoidal choroidal vasculopathy.
    Otani A, Sasahara M, Yodoi Y, Aikawa H, Tamura H, Tsujikawa A, Yoshimura N.
    Am J Ophthalmol; 2007 Jul; 144(1):7-14. PubMed ID: 17467649
    [Abstract] [Full Text] [Related]

  • 2. One-year outcomes of photodynamic therapy in age-related macular degeneration and polypoidal choroidal vasculopathy in Japanese patients.
    Gomi F, Ohji M, Sayanagi K, Sawa M, Sakaguchi H, Oshima Y, Ikuno Y, Tano Y.
    Ophthalmology; 2008 Jan; 115(1):141-6. PubMed ID: 17582498
    [Abstract] [Full Text] [Related]

  • 3. One-year results of reduced-fluence photodynamic therapy for polypoidal choroidal vasculopathy.
    Yamashita A, Shiraga F, Shiragami C, Ono A, Tenkumo K.
    Am J Ophthalmol; 2010 Mar; 149(3):465-71.e1. PubMed ID: 20042180
    [Abstract] [Full Text] [Related]

  • 4. Two-year results of reduced-fluence photodynamic therapy for polypoidal choroidal vasculopathy.
    Yamashita A, Shiraga F, Shiragami C, Shirakata Y, Fujiwara A.
    Am J Ophthalmol; 2013 Jan; 155(1):96-102.e1. PubMed ID: 22995028
    [Abstract] [Full Text] [Related]

  • 5. Treatment of polypoidal choroidal vasculopathy with photodynamic therapy combined with intravitreal injections of ranibizumab.
    Tomita K, Tsujikawa A, Yamashiro K, Ooto S, Tamura H, Otani A, Nakayama Y, Yoshimura N.
    Am J Ophthalmol; 2012 Jan; 153(1):68-80.e1. PubMed ID: 21907965
    [Abstract] [Full Text] [Related]

  • 6. Two-year results of photodynamic therapy for polypoidal choroidal vasculopathy.
    Kurashige Y, Otani A, Sasahara M, Yodoi Y, Tamura H, Tsujikawa A, Yoshimura N.
    Am J Ophthalmol; 2008 Oct; 146(4):513-519. PubMed ID: 18614133
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Photodynamic therapy with verteporfin in polypoidal choroidal vasculopathy: results after 3 years of follow-up.
    Leal S, Silva R, Figueira J, Cachulo ML, Pires I, de Abreu JR, Cunha-Vaz JG.
    Retina; 2010 Sep; 30(8):1197-205. PubMed ID: 20827139
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Hemorrhagic complications after photodynamic therapy for polypoidal choroidal vasculopathy.
    Hirami Y, Tsujikawa A, Otani A, Yodoi Y, Aikawa H, Mandai M, Yoshimura N.
    Retina; 2007 Mar; 27(3):335-41. PubMed ID: 17460589
    [Abstract] [Full Text] [Related]

  • 12. Long-term efficacy and safety of verteporfin photodynamic therapy in combination with anti-vascular endothelial growth factor for polypoidal choroidal vasculopathy.
    Jain P, Anantharaman G, Gopalakrishnan M, Goyal A.
    Indian J Ophthalmol; 2018 Aug; 66(8):1119-1127. PubMed ID: 30038155
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Selective photodynamic therapy for neovascular age-related macular degeneration with polypoidal choroidal neovascularization.
    Eandi CM, Ober MD, Freund KB, Slakter JS, Yannuzzi LA.
    Retina; 2007 Sep; 27(7):825-31. PubMed ID: 17891004
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Association of LOC387715 A69S genotype with visual prognosis after photodynamic therapy for polypoidal choroidal vasculopathy.
    Sakurada Y, Kubota T, Imasawa M, Mabuchi F, Tanabe N, Iijima H.
    Retina; 2010 Sep; 30(10):1616-21. PubMed ID: 20671585
    [Abstract] [Full Text] [Related]

  • 19. Intravitreal ranibizumab with or without photodynamic therapy for the treatment of symptomatic polypoidal choroidal vasculopathy.
    Lai TY, Lee GK, Luk FO, Lam DS.
    Retina; 2011 Sep; 31(8):1581-8. PubMed ID: 21610566
    [Abstract] [Full Text] [Related]

  • 20. One-year results of intravitreal ranibizumab with or without photodynamic therapy for polypoidal choroidal vasculopathy.
    Song MH, Ryu HW, Roh YJ.
    Ophthalmologica; 2011 Sep; 226(3):119-26. PubMed ID: 21757883
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.